{"id":7326,"date":"2025-06-05T12:21:17","date_gmt":"2025-06-05T12:21:17","guid":{"rendered":"https:\/\/stoxpo.com\/?p=7326"},"modified":"2025-06-05T12:21:17","modified_gmt":"2025-06-05T12:21:17","slug":"telomir-pharmaceuticals-reports-breakthrough-anti-aging-results-in-preclinical-werner-syndrome-model","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2025\/06\/05\/telomir-pharmaceuticals-reports-breakthrough-anti-aging-results-in-preclinical-werner-syndrome-model\/","title":{"rendered":"Telomir Pharmaceuticals Reports Breakthrough Anti-Aging Results in Preclinical Werner Syndrome Model"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Lead candidate Telomir-1 reverses aging markers, restores muscle mass, and boosts survival in genetic progeria model<\/h4>\n\n\n\n<p>Telomir Pharmaceuticals (TELO), a rising innovator in age-reversal science, has announced new preclinical data showing that its lead drug candidate, Telomir-1, dramatically reverses key aging markers in a vertebrate model of Werner Syndrome (WS), a rare genetic disorder often referred to as adult-onset progeria.<\/p>\n\n\n\n<p>In a 14-day study using a genetically validated zebrafish model of WS, Telomir-1 delivered a range of compelling results: it significantly elongated telomeres, reversed muscle and body weight loss, restored proper gene regulation through epigenetic repair, reduced oxidative stress, and improved survival rates.<\/p>\n\n\n\n<p>Werner Syndrome is caused by mutations in the <em>wrn<\/em> gene, which plays a crucial role in DNA repair and telomere maintenance. Patients typically experience accelerated aging symptoms\u2014graying hair, diabetes, osteoporosis, and cardiovascular complications\u2014in their 20s or 30s, with a median life expectancy of just 40\u201350 years. Currently, there are no FDA-approved treatments.<\/p>\n\n\n\n<p><strong>Key Findings:<\/strong><\/p>\n\n\n\n<ul>\n<li><strong>DNA Methylation Reversal:<\/strong> Telomir-1 successfully reset age-related DNA methylation patterns at two chromosomal regions, restoring gene regulation and potentially lowering the risk of diseases like cancer, Alzheimer\u2019s, and autoimmune disorders.<\/li>\n\n\n\n<li><strong>Telomere Elongation:<\/strong> The drug increased telomere length by approximately three-fold, surpassing even healthy control levels at higher doses. Telomere restoration is seen as a crucial step in combating cellular aging.<\/li>\n\n\n\n<li><strong>Muscle and Weight Recovery:<\/strong> Zebrafish with the <em>wrn<\/em> mutation exhibited 50\u201360% reductions in muscle volume and weight. After Telomir-1 treatment, these metrics returned to levels indistinguishable from healthy animals.<\/li>\n\n\n\n<li><strong>Oxidative Stress Reduction:<\/strong> Reactive oxygen species (ROS), a major driver of cellular aging, were reduced by up to 50%.<\/li>\n\n\n\n<li><strong>Survival Advantage:<\/strong> While 15% of untreated animals died during the study, none of the Telomir-1-treated fish died, indicating a systemic benefit.<\/li>\n<\/ul>\n\n\n\n<p>\u201cThis may be one of the most important developments in the field of aging,\u201d said CEO Erez Aminov. \u201cThe consistency and strength of the data demand serious attention.\u201d<\/p>\n\n\n\n<p>Dr. Itzchak Angel, Chief Scientific Advisor, added: \u201cTelomir-1\u2019s ability to restore both genomic and epigenetic stability makes it a promising candidate for a foundational anti-aging therapy.\u201d<\/p>\n\n\n\n<p>You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2025\/06\/04\/amazon-to-invest-10-billion-in-north-carolina-to-expand-ai-infrastructure\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Amazon to Invest $10 Billion in North Carolina to Expand AI Infrastructure<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lead candidate Telomir-1 reverses aging markers, restores muscle mass, and boosts survival in genetic progeria model Telomir Pharmaceuticals (TELO), a rising innovator in age-reversal science, has announced new preclinical data showing that its lead drug candidate, Telomir-1, dramatically reverses key aging markers in a vertebrate model of Werner Syndrome (WS), a rare genetic disorder often [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1442,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"0","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"0","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]}},"categories":[309,359],"tags":[421,663,416,418,510,417,548],"coauthors":[454],"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/7326"}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=7326"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/7326\/revisions"}],"predecessor-version":[{"id":7327,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/7326\/revisions\/7327"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1442"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=7326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=7326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=7326"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=7326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}